Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

Effects of Inhaled Treprostinil Sodium for the Treatment of Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis
A Single-Dose, Dose-Escalating Study Exploring the Safety, Pharmacokinetics, and Pharmacodynamic Effects of Inhaled Treprostinil Sodium Using the Nebu-Tec OPTINEB Inhalation Device in Patients With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
UTWS Medical Center Dallas/St. Paul Univ. Hospital
mi
from
Dallas, TX
Effects of Inhaled Treprostinil Sodium for the Treatment of Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis
A Single-Dose, Dose-Escalating Study Exploring the Safety, Pharmacokinetics, and Pharmacodynamic Effects of Inhaled Treprostinil Sodium Using the Nebu-Tec OPTINEB Inhalation Device in Patients With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
UTWS Medical Center Dallas/St. Paul Univ. Hospital
mi
from
Dallas, TX
Click here to add this to my saved trials
Effects of Inhaled Treprostinil Sodium for the Treatment of Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis
A Single-Dose, Dose-Escalating Study Exploring the Safety, Pharmacokinetics, and Pharmacodynamic Effects of Inhaled Treprostinil Sodium Using the Nebu-Tec OPTINEB Inhalation Device in Patients With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Inova Heart and Vascular Institute
mi
from
Falls Church, VA
Effects of Inhaled Treprostinil Sodium for the Treatment of Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis
A Single-Dose, Dose-Escalating Study Exploring the Safety, Pharmacokinetics, and Pharmacodynamic Effects of Inhaled Treprostinil Sodium Using the Nebu-Tec OPTINEB Inhalation Device in Patients With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Inova Heart and Vascular Institute
mi
from
Falls Church, VA
Click here to add this to my saved trials
Patterns of Neurocircuitry Activation In Severe Asthma
Patterns of Neurocircuitry Activation In Severe Asthma
Status: Enrolling
Updated:  12/31/1969
UW Madison
mi
from
Madison, WI
Patterns of Neurocircuitry Activation In Severe Asthma
Patterns of Neurocircuitry Activation In Severe Asthma
Status: Enrolling
Updated: 12/31/1969
UW Madison
mi
from
Madison, WI
Click here to add this to my saved trials
Lung Tissue Research Consortium
Lung Tissue Research Consortium
Status: Enrolling
Updated:  12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Lung Tissue Research Consortium
Lung Tissue Research Consortium
Status: Enrolling
Updated: 12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Lung Tissue Research Consortium
Lung Tissue Research Consortium
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Rochester
mi
from
Rochester, MN
Lung Tissue Research Consortium
Lung Tissue Research Consortium
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Lung Tissue Research Consortium
Lung Tissue Research Consortium
Status: Enrolling
Updated:  12/31/1969
Temple University
mi
from
Philadelphia, PA
Lung Tissue Research Consortium
Lung Tissue Research Consortium
Status: Enrolling
Updated: 12/31/1969
Temple University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Lung Tissue Research Consortium
Lung Tissue Research Consortium
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh
mi
from
Pittsburgh, PA
Lung Tissue Research Consortium
Lung Tissue Research Consortium
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Atomoxetine for Treating Cocaine Abuse in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Atomoxetine Treatment for Cocaine Abuse and Adult Attention-Deficit Hyperactivity Disorder (ADHD): A Preliminary Open Trial
Status: Enrolling
Updated:  12/31/1969
Research Foundation for Mental Hygiene, Inc.
mi
from
New York, NY
Atomoxetine for Treating Cocaine Abuse in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Atomoxetine Treatment for Cocaine Abuse and Adult Attention-Deficit Hyperactivity Disorder (ADHD): A Preliminary Open Trial
Status: Enrolling
Updated: 12/31/1969
Research Foundation for Mental Hygiene, Inc.
mi
from
New York, NY
Click here to add this to my saved trials
Dose Response Trial of Pergolide for Cocaine Dependence - 1
Dose Response Trial of Pergolide for Cocaine Dependence
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Dose Response Trial of Pergolide for Cocaine Dependence - 1
Dose Response Trial of Pergolide for Cocaine Dependence
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) in Methadone Patients - 1
Treatment of Adult ADHD in Methadone Patients
Status: Enrolling
Updated:  12/31/1969
Research Foundation for Mental Hygiene, Inc.
mi
from
New York, NY
Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) in Methadone Patients - 1
Treatment of Adult ADHD in Methadone Patients
Status: Enrolling
Updated: 12/31/1969
Research Foundation for Mental Hygiene, Inc.
mi
from
New York, NY
Click here to add this to my saved trials
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated:  12/31/1969
Indiana Clinical Research Center, IU Health University Hospital
mi
from
Indianapolis, IN
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated: 12/31/1969
Indiana Clinical Research Center, IU Health University Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated:  12/31/1969
Boston Children's Hospital
mi
from
Boston, MA
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated: 12/31/1969
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated:  12/31/1969
Children's Mercy Hospital
mi
from
Kansas City, MO
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated: 12/31/1969
Children's Mercy Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine and St. Louis Children's Hospital
mi
from
Saint Louis, MO
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine and St. Louis Children's Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated:  12/31/1969
Albany Medical College
mi
from
Albany, NY
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated: 12/31/1969
Albany Medical College
mi
from
Albany, NY
Click here to add this to my saved trials
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated:  12/31/1969
Northwell Health, Long Island Jewish Medical Center
mi
from
New Hyde Park, NY
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated: 12/31/1969
Northwell Health, Long Island Jewish Medical Center
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center
mi
from
New York, NY
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated:  12/31/1969
SUNY Upstate Medical University
mi
from
Syracuse, NY
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated: 12/31/1969
SUNY Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated:  12/31/1969
Respiratory Diseases of Children and Adolescents
mi
from
Oklahoma City, OK
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated: 12/31/1969
Respiratory Diseases of Children and Adolescents
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Pittsburgh - University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Pittsburgh - University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated:  12/31/1969
University of Tennessee Medical Center-Adult Cystic Fibrosis Clinic
mi
from
Knoxville, TN
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated: 12/31/1969
University of Tennessee Medical Center-Adult Cystic Fibrosis Clinic
mi
from
Knoxville, TN
Click here to add this to my saved trials
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated:  12/31/1969
Baylor College of Medicine
mi
from
Houston, TX
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated: 12/31/1969
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated:  12/31/1969
Seattle Children's Hospital
mi
from
Seattle, WA
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated: 12/31/1969
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated:  12/31/1969
Helen DeVos Children's Hospital CF Center
mi
from
Grand Rapids, MI
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated: 12/31/1969
Helen DeVos Children's Hospital CF Center
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated:  12/31/1969
Rutgers Robert Wood Johnson Medical School
mi
from
New Brunswick, NJ
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated: 12/31/1969
Rutgers Robert Wood Johnson Medical School
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated:  12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated: 12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated:  12/31/1969
Sanford Research/USD
mi
from
Sioux Falls, SD
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated: 12/31/1969
Sanford Research/USD
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated:  12/31/1969
University of Miami Miller School of Medicine
mi
from
Miami, FL
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated: 12/31/1969
University of Miami Miller School of Medicine
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated:  12/31/1969
St. Luke's CF Center of Idaho
mi
from
Boise, ID
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated: 12/31/1969
St. Luke's CF Center of Idaho
mi
from
Boise, ID
Click here to add this to my saved trials
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated:  12/31/1969
University of Utah / Primary Childrens Medical Center
mi
from
Salt Lake City, UT
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated: 12/31/1969
University of Utah / Primary Childrens Medical Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated:  12/31/1969
Children's Foundation Research Center / Le Bonheur Children's Hospital
mi
from
Memphis, TN
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated: 12/31/1969
Children's Foundation Research Center / Le Bonheur Children's Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated:  12/31/1969
Yale New-Haven Medical Center
mi
from
New Haven, CT
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated: 12/31/1969
Yale New-Haven Medical Center
mi
from
New Haven, CT
Click here to add this to my saved trials
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated:  12/31/1969
Advocate Children's Hospital - Park Ridge / North Suburban Pulmonary and Critical Care Consultants
mi
from
Niles, IL
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated: 12/31/1969
Advocate Children's Hospital - Park Ridge / North Suburban Pulmonary and Critical Care Consultants
mi
from
Niles, IL
Click here to add this to my saved trials
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated:  12/31/1969
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated: 12/31/1969
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated:  12/31/1969
Alfred Hospital
mi
from
Melbourne,
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
Status: Enrolling
Updated: 12/31/1969
Alfred Hospital
mi
from
Melbourne,
Click here to add this to my saved trials
Comparison of 133Xe Scintigraphy With 19F MRI
Comparison of 133Xe Scintigraphy With 19F MRI for Evaluation of Lung Ventilation Function: A Non-Inferiority Comparison (DIAL1001007)
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Comparison of 133Xe Scintigraphy With 19F MRI
Comparison of 133Xe Scintigraphy With 19F MRI for Evaluation of Lung Ventilation Function: A Non-Inferiority Comparison (DIAL1001007)
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
The POSAtive Study: Study for the Treatment of Positional Obstructive Sleep Apnea
A Prospective, Randomized, Crossover Study of the NightBalance Sleep Position Trainer (SPT) Compared to Automatic Adjusting Positive Airway Pressure (APAP) for the Treatment of Positional Obstructive Sleep Apnea (POSA)
Status: Enrolling
Updated:  12/31/1969
Sleep Disorders Center of Alabama
mi
from
Birmingham, AL
The POSAtive Study: Study for the Treatment of Positional Obstructive Sleep Apnea
A Prospective, Randomized, Crossover Study of the NightBalance Sleep Position Trainer (SPT) Compared to Automatic Adjusting Positive Airway Pressure (APAP) for the Treatment of Positional Obstructive Sleep Apnea (POSA)
Status: Enrolling
Updated: 12/31/1969
Sleep Disorders Center of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
The POSAtive Study: Study for the Treatment of Positional Obstructive Sleep Apnea
A Prospective, Randomized, Crossover Study of the NightBalance Sleep Position Trainer (SPT) Compared to Automatic Adjusting Positive Airway Pressure (APAP) for the Treatment of Positional Obstructive Sleep Apnea (POSA)
Status: Enrolling
Updated:  12/31/1969
Sleep Med Inc., AZ
mi
from
Glendale, AZ
The POSAtive Study: Study for the Treatment of Positional Obstructive Sleep Apnea
A Prospective, Randomized, Crossover Study of the NightBalance Sleep Position Trainer (SPT) Compared to Automatic Adjusting Positive Airway Pressure (APAP) for the Treatment of Positional Obstructive Sleep Apnea (POSA)
Status: Enrolling
Updated: 12/31/1969
Sleep Med Inc., AZ
mi
from
Glendale, AZ
Click here to add this to my saved trials
The POSAtive Study: Study for the Treatment of Positional Obstructive Sleep Apnea
A Prospective, Randomized, Crossover Study of the NightBalance Sleep Position Trainer (SPT) Compared to Automatic Adjusting Positive Airway Pressure (APAP) for the Treatment of Positional Obstructive Sleep Apnea (POSA)
Status: Enrolling
Updated:  12/31/1969
Sleep Disorders at Magnolia Park
mi
from
Gainesville, FL
The POSAtive Study: Study for the Treatment of Positional Obstructive Sleep Apnea
A Prospective, Randomized, Crossover Study of the NightBalance Sleep Position Trainer (SPT) Compared to Automatic Adjusting Positive Airway Pressure (APAP) for the Treatment of Positional Obstructive Sleep Apnea (POSA)
Status: Enrolling
Updated: 12/31/1969
Sleep Disorders at Magnolia Park
mi
from
Gainesville, FL
Click here to add this to my saved trials
The POSAtive Study: Study for the Treatment of Positional Obstructive Sleep Apnea
A Prospective, Randomized, Crossover Study of the NightBalance Sleep Position Trainer (SPT) Compared to Automatic Adjusting Positive Airway Pressure (APAP) for the Treatment of Positional Obstructive Sleep Apnea (POSA)
Status: Enrolling
Updated:  12/31/1969
Kentucky Research Group
mi
from
Louisville, KY
The POSAtive Study: Study for the Treatment of Positional Obstructive Sleep Apnea
A Prospective, Randomized, Crossover Study of the NightBalance Sleep Position Trainer (SPT) Compared to Automatic Adjusting Positive Airway Pressure (APAP) for the Treatment of Positional Obstructive Sleep Apnea (POSA)
Status: Enrolling
Updated: 12/31/1969
Kentucky Research Group
mi
from
Louisville, KY
Click here to add this to my saved trials
The POSAtive Study: Study for the Treatment of Positional Obstructive Sleep Apnea
A Prospective, Randomized, Crossover Study of the NightBalance Sleep Position Trainer (SPT) Compared to Automatic Adjusting Positive Airway Pressure (APAP) for the Treatment of Positional Obstructive Sleep Apnea (POSA)
Status: Enrolling
Updated:  12/31/1969
The Center for Sleep and Wake Disorders
mi
from
Chevy Chase, MD
The POSAtive Study: Study for the Treatment of Positional Obstructive Sleep Apnea
A Prospective, Randomized, Crossover Study of the NightBalance Sleep Position Trainer (SPT) Compared to Automatic Adjusting Positive Airway Pressure (APAP) for the Treatment of Positional Obstructive Sleep Apnea (POSA)
Status: Enrolling
Updated: 12/31/1969
The Center for Sleep and Wake Disorders
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
The POSAtive Study: Study for the Treatment of Positional Obstructive Sleep Apnea
A Prospective, Randomized, Crossover Study of the NightBalance Sleep Position Trainer (SPT) Compared to Automatic Adjusting Positive Airway Pressure (APAP) for the Treatment of Positional Obstructive Sleep Apnea (POSA)
Status: Enrolling
Updated:  12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
The POSAtive Study: Study for the Treatment of Positional Obstructive Sleep Apnea
A Prospective, Randomized, Crossover Study of the NightBalance Sleep Position Trainer (SPT) Compared to Automatic Adjusting Positive Airway Pressure (APAP) for the Treatment of Positional Obstructive Sleep Apnea (POSA)
Status: Enrolling
Updated: 12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
The POSAtive Study: Study for the Treatment of Positional Obstructive Sleep Apnea
A Prospective, Randomized, Crossover Study of the NightBalance Sleep Position Trainer (SPT) Compared to Automatic Adjusting Positive Airway Pressure (APAP) for the Treatment of Positional Obstructive Sleep Apnea (POSA)
Status: Enrolling
Updated:  12/31/1969
St. Luke's Sleep Medicine and Research Center
mi
from
Chesterfield, MO
The POSAtive Study: Study for the Treatment of Positional Obstructive Sleep Apnea
A Prospective, Randomized, Crossover Study of the NightBalance Sleep Position Trainer (SPT) Compared to Automatic Adjusting Positive Airway Pressure (APAP) for the Treatment of Positional Obstructive Sleep Apnea (POSA)
Status: Enrolling
Updated: 12/31/1969
St. Luke's Sleep Medicine and Research Center
mi
from
Chesterfield, MO
Click here to add this to my saved trials
The POSAtive Study: Study for the Treatment of Positional Obstructive Sleep Apnea
A Prospective, Randomized, Crossover Study of the NightBalance Sleep Position Trainer (SPT) Compared to Automatic Adjusting Positive Airway Pressure (APAP) for the Treatment of Positional Obstructive Sleep Apnea (POSA)
Status: Enrolling
Updated:  12/31/1969
Clayton Sleep Institute
mi
from
Maplewood, MO
The POSAtive Study: Study for the Treatment of Positional Obstructive Sleep Apnea
A Prospective, Randomized, Crossover Study of the NightBalance Sleep Position Trainer (SPT) Compared to Automatic Adjusting Positive Airway Pressure (APAP) for the Treatment of Positional Obstructive Sleep Apnea (POSA)
Status: Enrolling
Updated: 12/31/1969
Clayton Sleep Institute
mi
from
Maplewood, MO
Click here to add this to my saved trials
The POSAtive Study: Study for the Treatment of Positional Obstructive Sleep Apnea
A Prospective, Randomized, Crossover Study of the NightBalance Sleep Position Trainer (SPT) Compared to Automatic Adjusting Positive Airway Pressure (APAP) for the Treatment of Positional Obstructive Sleep Apnea (POSA)
Status: Enrolling
Updated:  12/31/1969
Med One Sleep
mi
from
Fayetteville, NC
The POSAtive Study: Study for the Treatment of Positional Obstructive Sleep Apnea
A Prospective, Randomized, Crossover Study of the NightBalance Sleep Position Trainer (SPT) Compared to Automatic Adjusting Positive Airway Pressure (APAP) for the Treatment of Positional Obstructive Sleep Apnea (POSA)
Status: Enrolling
Updated: 12/31/1969
Med One Sleep
mi
from
Fayetteville, NC
Click here to add this to my saved trials
The POSAtive Study: Study for the Treatment of Positional Obstructive Sleep Apnea
A Prospective, Randomized, Crossover Study of the NightBalance Sleep Position Trainer (SPT) Compared to Automatic Adjusting Positive Airway Pressure (APAP) for the Treatment of Positional Obstructive Sleep Apnea (POSA)
Status: Enrolling
Updated:  12/31/1969
Pearl Clinical Research
mi
from
Paoli, PA
The POSAtive Study: Study for the Treatment of Positional Obstructive Sleep Apnea
A Prospective, Randomized, Crossover Study of the NightBalance Sleep Position Trainer (SPT) Compared to Automatic Adjusting Positive Airway Pressure (APAP) for the Treatment of Positional Obstructive Sleep Apnea (POSA)
Status: Enrolling
Updated: 12/31/1969
Pearl Clinical Research
mi
from
Paoli, PA
Click here to add this to my saved trials